As of November 13, 2024, Johnson & Johnson had a $368.9 billion market capitalization, compared to the Pharmaceuticals median of $278.4 million. Johnson & Johnson’s stock is down 2.3% in 2024, down ...

Currently, Johnson & Johnson’s price-earnings ratio is 25.1. Johnson & Johnson’s trailing 12-month revenue is $87.7 billion with a 16.7% net profit margin. Year-over-year quarterly sales growth most ...

Johnson & Johnson was founded over 125 years ago in the year 1886. However, it wasn't until 1959 – 73 years and two major acquisitions later – that J&J developed its significant presence in ...

Johnson & Johnson’s Consumer Health segment reported a revenue of $14.6 billion in the Full-Year 2021. It is projected that, following the separation, Kenvue will generate sales in over 100 ...

There are some well-documented perks to being the child of a celebrity — or in the case of Dakota Johnson, the 35-year-old daughter of Don Johnson and Melanie Griffith, the child of two celebrities.

Dwayne Johnson hopes to inspire young girls to follow ... The 52-year-old actor stars in the new Disney animation Moana 2 and Dwayne observed that the movie centers on the theme of “female ...

"It is a new day in America," Johnson said surrounded by GOP leadership. Speaker Mike Johnson and top House Republicans took a victory lap as they returned to Washington on Tuesday on the heels of ...

These large and stable companies offer strong long-term opportunities heading into 2025.

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments ...

Johnson & Johnson has sued a U.S. government agency over a closely watched dispute focusing on payment methods for some hospitals that participate in a federal drug discount program. In its ...

Johnson Controls (JCI) delivered earnings and revenue surprises of 2.40% and 13.96%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?